RecruitingEarly Phase 1NCT04480645

CivaDerm(TM) Surface Therapy Pilot Study


Sponsor

CivaTech Oncology

Enrollment

10 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a pilot study to determine the usefulness of new brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit basal cell and squamous cell carcinoma patients by providing conformal radiation therapy to the surface of the skin.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This pilot study tests a skin-surface radiation device called CivaDerm for treating non-melanoma skin cancers (basal cell or squamous cell carcinoma) on the body. It delivers targeted low-dose radiation directly to the tumor site from the outside. **You may be eligible if...** - You have been diagnosed with basal cell carcinoma or squamous cell carcinoma confirmed by biopsy - The cancer is located on your chest, stomach, back, arms, legs, or feet - Your tumor is between 5mm and 3cm in size - You are able to follow the patient care instructions **You may NOT be eligible if...** - You are pregnant or breastfeeding - Your cancer has spread to other parts of the body (metastatic) - You are unable or unwilling to follow the study protocol Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECivaDerm

radioactive bandage


Locations(1)

CivaDerm Oncology PLLC

Morrisville, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04480645


Related Trials